Jane Street’s Telix Pharmaceuticals TLX Stock Holding History

Jane Street’s Portfolio TLX Stock Details TLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$385K	Buy	+33,389	New	+$340K	﹤0.01%	8622
2026 Q1	–	Sell	-40,042	Closed	-$300K	–	13342
2025 Q4	$300K	Sell	40,042 -32,950	-45%	-$317K	﹤0.01%	8840
2025 Q3	$699K	Buy	72,992 +37,889	+108%	+$464K	﹤0.01%	7099
2025 Q2	$564K	Buy	+35,103	New	+$589K	﹤0.01%	6693

Other funds holding TLX

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

PIC

Portland Investment Counsel Burlington, Ontario, Canada $358M AUM 26.37% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

RBI

Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Jane Street's TLX Position: Q2 2026 in Review

Jane Street opened a new position in Telix Pharmaceuticals (TLX) in Q2 2026: 33,389 shares worth $385K. The stake represents ﹤0.01% of the portfolio and ranks #8622 among its holdings. This is a return to the name: Jane Street previously reported a position in TLX as recently as Q4 2025.

Jane Street first reported a position in TLX in Q2 2025 and has held it in 4 quarters since. The position peaked at $699K in Q3 2025. 56 funds tracked by Wall St. Rank hold TLX as of Q2 2026.

Jane Street held 33,389 shares of Telix Pharmaceuticals worth $385K as of Q2 2026.
Telix Pharmaceuticals was a new Jane Street position in Q2 2026.
Telix Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8622 holding.
Jane Street first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
Jane Street's Telix Pharmaceuticals position peaked at $699K in Q3 2025.
56 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.